Goodluck India Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Goodluck India Ltd filed with BSE on 17 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Goodluck India reported consolidated Q1 FY27 revenue growth of 31%, EBITDA growth of 46% and PAT growth of 67%, with the Defence segment contributing INR80 crores of revenue at 38% EBITDA margin. Management said the company received Defence orders worth INR255 crores and INR52 crores for artillery shells, and disclosed that a planned capacity expansion has been delayed by 6 to 9 months due to financial closure. Management also discussed a preferential share issue in its Defence and Aerospace subsidiary at INR375 per share, raising INR285 crores, and fielded multiple questions from analysts about the structure and valuation of that transaction.
1 statement from this call is not shown because its supporting quote could not be reproduced within our quoting limits. Nothing shown here is affected: every statement on this page carries its verified quote.
Numbers mentioned
Standalone income from operations: INR1,205.94 crores (Q1 FY27)
p. 6
“the income from operations was at INR1,205.94 crores as against INR983.29 crores during Q1 of previous year”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Standalone EBITDA: INR110.53 crores (Q1 FY27)
p. 6
“EBITDA for the quarter increased by 15%, stood at INR110.53 crores as against INR95.78 crores”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Standalone PAT: INR49.66 crores (Q1 FY27)
p. 6
“Profit after tax, including other comprehensive income was INR49.66 crores in Q1 of FY27 as compared to INR40.14 crores in Q1 of 2026”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Standalone EPS: INR14.94 per share (Q1 FY27)
p. 6
“The earnings per share has been at INR14.94 per share in Q1 '27 as against INR12.62 during Q1 of previous year”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Consolidated total income: INR1,287.44 crores (Q1 FY27)
p. 6
“Total income increased by 31% at INR1,287.44 crores as compared to INR983.29 crores during Q1 of previous year”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Consolidated EBITDA: INR139.66 crores (Q1 FY27)
p. 6
“EBITDA was INR139.66 crores as against INR95.80 crores, registered an increase of 46%”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Consolidated PAT: INR67.22 crores (Q1 FY27)
p. 6
“PAT during Q1 of current year was INR67.22 crores, registering a growth of 67% on a year-on-year basis”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Consolidated EPS: INR19.13 per share (Q1 FY27)
p. 6
“Earnings per share stood at INR19.13 per share during Q1 of current year as against INR12.62 per share during FY26, registering a growth of 52% over previous year”
Sanjay Bansal, page 6 of the filed PDF · View the filing
Standalone volume: 1,22,718 metric tons (Q1 FY27)
p. 4
“stand-alone volume has increased 8.8% Y-o-Y to 1,22,718 metric tons”
Ram Aggarwal, page 4 of the filed PDF · View the filing
Annualized capacity utilization: 98% (Q1 FY27)
p. 4
“annualized capacity utilization remains strong at 98%”
Ram Aggarwal, page 4 of the filed PDF · View the filing
Defence order value: INR255 crores
p. 4
“Goodluck Defence and Aerospace Limited received an order of INR255 crores for 155 mm long-range, ready-to-fill empty shells to be executed over 10 months”
Ram Aggarwal, page 4 of the filed PDF · View the filing
Defence order value (second order): INR52 crores
p. 4
“it received an order of INR52 crores for 20,000 155 mm shell with execution over 3 months”
Ram Aggarwal, page 4 of the filed PDF · View the filing
Defence segment revenue: 80 crores (Q1 FY27)
p. 9
“It was 80 crores and with a EBITDA of 38%.”
Ram Aggarwal, page 9 of the filed PDF · View the filing
Debt repaid: INR25 crores (Q1 FY27)
p. 9
“Yes. We have repaid INR25 crores.”
Sanjay Bansal, page 9 of the filed PDF · View the filing
Total debt repayment planned: INR62 crores (FY27)
p. 9
“It would be INR62 crores.”
Sanjay Bansal, page 9 of the filed PDF · View the filing
Preferential issue price per share: INR375
p. 12
“we have given the per share rate also INR375”
Sanjay Bansal, page 12 of the filed PDF · View the filing
Shares issued in preferential issue: 75 lakh shares
p. 12
“We will have at this time, we are issuing almost 75 lakh shares.”
Ram Aggarwal, page 12 of the filed PDF · View the filing
Hydraulic tube capacity utilization: 60% to 65% (Q1 FY27)
p. 16
“This quarter, it has come to 60% to 65%.”
Ram Aggarwal, page 16 of the filed PDF · View the filing
EBITDA per metric ton: INR9,000 per metric ton (Q1 FY27)
p. 18
“This quarter also, our EBITDA per metric ton is INR9,000 per metric ton.”
Ram Aggarwal, page 18 of the filed PDF · View the filing
Volume growth: 9% (Q1 FY27)
p. 18
“As far as the volume this quarter, it has gone up by 9%.”
Ram Aggarwal, page 18 of the filed PDF · View the filing
Stake diluted in subsidiary: 10.5%
p. 19
“We have diluted 10.5%.”
Ram Aggarwal, page 19 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Defence segment revenue — INR300 crores to INR350 crores · FY27
stated firmly by Ram Aggarwal
p. 5
“In all, company aims to achieve INR300 crores to INR350 crores target this year with a marked EBITDA of 30% to 35%.”
Ram Aggarwal, page 5 of the filed PDF · View the filing
Defence EBITDA margin — 30% to 35% · FY27
stated firmly by Ram Aggarwal
p. 19
“EBITDA margin, what guidance I have given 30% to 35%. I still hold my guidance for the EBITDA margin.”
Ram Aggarwal, page 19 of the filed PDF · View the filing
Overall top-line growth — 15% to 20% · FY27
stated firmly by Ram Aggarwal
p. 18
“We maintain our guidance that it should be 15% to 20%.”
Ram Aggarwal, page 18 of the filed PDF · View the filing
Defence capacity expansion commissioning — Q4 FY27
stated conditionally by Ram Aggarwal
p. 15
“We hope by the quarter 4 of this financial year, expansion should start.”
Ram Aggarwal, page 15 of the filed PDF · View the filing
Defence shell capacity post-expansion — 350,000 shells per annum
stated firmly by Ram Aggarwal
p. 15
“The plant capacity will be 4 lakh, but the achievable capacity is always 90%. So it should be almost 350,000 shells per annum.”
Ram Aggarwal, page 15 of the filed PDF · View the filing
Defence subsidiary capex — INR400 crores
stated firmly by Ram Aggarwal
p. 14
“Capex in the Defence sector, we have already given it should be almost INR400 crores.”
Ram Aggarwal, page 14 of the filed PDF · View the filing
Standalone unit capex — INR100 crores to INR150 crores
stated firmly by Ram Aggarwal
p. 14
“for the current for the stand-alone division -- stand-alone unit, it will be -- it should be almost INR100 crores to INR150 crores.”
Ram Aggarwal, page 14 of the filed PDF · View the filing
Defence subsidiary IPO timeline — 18 months
stated conditionally by Ram Aggarwal
p. 8
“We hope that 18 months from today, it should be the time. But however, again, it will depend on the approvals and the systems.”
Ram Aggarwal, page 8 of the filed PDF · View the filing
Hydraulic tube business turnover — double · 4, 5 years
stated as an aspiration by Ram Aggarwal
p. 5
“Right now, we are doing almost INR1,000 crores plus turnover in this product, and we would like to double it in the coming 4, 5 years.”
Ram Aggarwal, page 5 of the filed PDF · View the filing
GI/precision pipe capacity ramp-up — 6 months
stated conditionally by Ram Aggarwal
p. 20
“So what we had told last time for the GI tubes, this DOM tubes, this capacity and the tube capacity, it is likely to come in next 6 months.”
Ram Aggarwal, page 20 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said the listing plan was advised by financial consultants and would still benefit Goodluck Group shareholders as it is a subsidiary.
Answered by Ram Aggarwal
Asked by Nishita: Why is the company listing the Defence subsidiary separately rather than demerging it to shareholders?
p. 7
“But this current listing, listing will also create the value for the current shareholders as well.”
Ram Aggarwal, page 7 of the filed PDF · View the filing
Management attributed the delay to the financial closure process for the project.
Answered by Ram Aggarwal
Asked by Shubham: Why has the ramp-up of the Defence expansion been delayed by 6 months versus earlier guidance?
p. 8
“Basically, it is a financial closure. Now the financial closure is being done nowadays.”
Ram Aggarwal, page 8 of the filed PDF · View the filing
Management clarified the new project was delayed and that this year's turnover guidance is on the existing plant, not the delayed expansion.
Answered by Ram Aggarwal
Asked by Prateek Bhandari: Why did the FY27 Defence revenue guidance range change from INR250-300 crores to INR300-350 crores given the delay in new capacity?
p. 8
“First of all, I just clarified that the new project -- new project is delayed as we have declared in the SEBI filing also.”
Ram Aggarwal, page 8 of the filed PDF · View the filing
Management said input costs and logistics costs remain volatile due to the West Asia crisis and petroleum-linked inputs, and said they are taking steps to mitigate the impact.
Answered by Ram Aggarwal
Asked by Ritika Sheth: Are there input cost risks given geopolitical tensions?
p. 11
“Input cost risk is very high because war is going up and down.”
Ram Aggarwal, page 11 of the filed PDF · View the filing
Management said it chose external capital because it did not want to leverage the balance sheet and needed investor relationships for future expansion.
Answered by Ram Aggarwal
Asked by Shashank Kanodia: Why was the Defence subsidiary stake sold to external investors at what the analyst called an inexpensive valuation relative to peers?
p. 16
“So we have opted for this because there are too many targets in the future where we will be needing our -- these friends, these investors.”
Ram Aggarwal, page 16 of the filed PDF · View the filing
Management said value-added products already account for about 60% of the business and that share will keep rising as legacy business shrinks.
Answered by Ram Aggarwal
Asked by Mahima Gidwani: Which products are driving value-added growth and how much room remains before new capacities come online?
p. 20
“Value-added, we have almost 60% we are already there. And in the coming years, this will increase and the legacy business, it will get reduced due to the increase in the value-added business.”
Ram Aggarwal, page 20 of the filed PDF · View the filing
Risks flagged
Input cost volatility linked to petroleum products amid geopolitical conflict
p. 11
“So all the petroleum products get volatile and the petroleum products are in every product, whether we use packing material, whether we use gas, everywhere, this is a petroleum.”
Ram Aggarwal, page 11 of the filed PDF · View the filing
Logistics cost volatility from the West Asia crisis
p. 11
“the logistic cost, it goes up and down by this West Asia crisis. So that is a concern.”
Ram Aggarwal, page 11 of the filed PDF · View the filing
Delay in Defence capacity expansion due to approvals and regulatory processes
p. 8
“It all depends on the approvals and regulatory systems because that is a major point in this all, whatever we plan, approvals and regulations are always important.”
Ram Aggarwal, page 8 of the filed PDF · View the filing
Impact of West Asia crisis on realization improvement and capacity ramp-up
p. 10
“In this quarter, it has not increased much. But in the coming quarters, because this quarter was impacted by the West Asia crisis.”
Ram Aggarwal, page 10 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.